Clinical trial

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the…

NCT00336544 · Advanced Life Sciences, Inc., Industry · Completed

Key facts

NCT number NCT00336544
Title Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
Official title A Double-Blinded, Randomized, Parallel Group, Multi-Center, Multi-National Comparative Study of the Safety and Efficacy of Cethromycin 300 mg QD to Clarithromycin 250 mg BID for the Treatment of Community-Acquired Pneumonia in Adults
Lead sponsor Advanced Life Sciences, Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pneumonia
Intervention type Drug
Interventions Cethromycin, Clarithromycin
Enrollment 522
Start date Jun 1, 2006
Primary completion May 1, 2007
Completion May 1, 2007
First posted Jun 13, 2006
Last update posted Feb 26, 2010
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies